These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22536637)

  • 1. [Does the asymptomatic carriage of FV Leiden and FII prothrombin in heterozygous configuration represent the increased risk of thrombembolic complications during pregnancy, childbirth and postpartum?].
    Binder T; Vavrinková B; Hadacová I; Hrachovinová I; Salaj P; Hruda M
    Ceska Gynekol; 2012 Feb; 77(1):25-30. PubMed ID: 22536637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does asymptomatic carriage of FV Leiden and FII prothrombin mutations in heterozygous configuration pose an increased risk of thrombembolic complications in the course of pregnancy, labor and puerperium?
    Vavrinkova B; Binder T; Hadacova I; Hrachovinova I; Salaj P; Hruda M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Jun; 158(2):238-41. PubMed ID: 23128846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium].
    Dordević V; Rakićević L; Spasić M; Miković D; Kovać M; Radojković D
    Vojnosanit Pregl; 2005 Mar; 62(3):201-5. PubMed ID: 15790048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.
    Couto E; Nomura ML; Barini R; Pinto e Silva JL
    Sao Paulo Med J; 2005 Nov; 123(6):286-8. PubMed ID: 16444389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.
    Yilmazer M; Kurtay G; Sonmezer M; Akar N
    Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
    Cordoba I; Pegenaute C; González-López TJ; Chillon C; Sarasquete ME; Martin-Herrero F; Guerrero C; Cabrero M; Garcia Sanchez MH; Pabon P; Lozano FS; Gonzalez M; Alberca I; González-Porras JR
    Eur J Haematol; 2012 Sep; 89(3):250-5. PubMed ID: 22642978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.
    Martinelli I; Battaglioli T; De Stefano V; Tormene D; Valdrè L; Grandone E; Tosetto A; Mannucci PM;
    J Thromb Haemost; 2008 Mar; 6(3):494-8. PubMed ID: 18182035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
    Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
    Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy-associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone.
    Samama MM; Rached RA; Horellou MH; Aquilanti S; Mathieux VG; Plu-Bureau G; Elalamy I; Conard J
    Br J Haematol; 2003 Oct; 123(2):327-34. PubMed ID: 14531916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation.
    Kjellberg U; van Rooijen M; Bremme K; Hellgren M
    Thromb Res; 2014 Oct; 134(4):837-45. PubMed ID: 25135795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnancy-associated venous thrombosis in women with hereditary heterozygous factor V Leiden and/or factor II gene mutations].
    Samama MM; Rached RA; Conard J; Horellou MH; Elalamy I
    Bull Acad Natl Med; 2004; 188(8):1377-93; discussion 1393-6. PubMed ID: 15918665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene mutations in patients with severe pregnancy complications in northern Finland.
    Jarvenpaa J; Pakkila M; Savolainen ER; Perheentupa A; Jarvela I; Ryynanen M
    Gynecol Obstet Invest; 2006; 62(1):28-32. PubMed ID: 16514238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran.
    Bagheri M; Rad IA; Nanbakhsh F
    Arch Gynecol Obstet; 2011 Nov; 284(5):1311-5. PubMed ID: 21773779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms.
    Jacobsen AF; Dahm A; Bergrem A; Jacobsen EM; Sandset PM
    J Thromb Haemost; 2010 Nov; 8(11):2443-9. PubMed ID: 20735725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Activated Protein C Response Rates Reduce the Thrombotic Risk of Factor V Leiden Carriers But Not of Prothrombin 20210G>A Carriers.
    Rühl H; Berens C; Winterhagen FI; Reda S; Müller J; Oldenburg J; Pötzsch B
    Circ Res; 2019 Aug; 125(5):523-534. PubMed ID: 31314700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The frequency of venous thromboembolism in women with Leiden mutation in association with pregnancy and puerperium].
    Dulícek P; Malý J; Kalousek I; Beránek M; Pecka M
    Ceska Gynekol; 2005 Mar; 70(2):133-8. PubMed ID: 15918268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.